News Tagged ‘Illinois

Baxter faces numerous lawsuits over tainted heparin scandal

blood cells 100x100As many as 300 product-liability lawsuits may be filed in the Illinois state court against drug maker Baxter International Inc., by people injured by or families who lost loved ones to contaminated batches of the heparin. Per a judge’s order last year, attorneys are working to convert an aggregate lawsuit to individual claims against the Deerfield, Illinois-based drug company.

Read the rest of this entry »

Four lawsuits filed in contaminated heparin case

Four lawsuits were filed last month in Cook County, Illinois court against the makers of the heparin, claiming the product the company manufactured was contaminated and caused patients to die.

Read the rest of this entry »

Class action lawsuit filed against Baxter over tainted heparin scandal

A class action lawsuit has been filed against Baxter claiming the drug maker substituted an ingredient in its heparin with a cheaper, more dangerous one in order to reap more profits, according to the Madison-St. Clair The Record. Twenty-eight people are named in the lawsuit, most of whom are spouses of individuals who died after receiving injections of the tainted heparin. The lawsuit was filed in St. Clair County Court in Illinois.

Read the rest of this entry »

Two sentenced for role in tainted heparin, saline syringes

syringe 100x100In an effort to ship heparin- and saline-filled syringes faster, workers at a facility in North Carolina failed to check sterility and then falsified manufacturing dates to make it appear those safeguards were followed, according to an Associated Press report. Those syringes, as it turned out, were tainted with a bacteria known as Serratia marcescens and may have lead to five deaths and hundreds of infections in those who received them.

Read the rest of this entry »

Class action lawsuit filed against heparin manufacturer Baxter

A class action lawsuit has been filed against Baxter Healthcare Corp., claiming the company began substituting ingredients in its anti-coagulant heparin with a dangerous counterfeit to “reap greater profits as a result of utilizing cheap component parts,” according to The Madison St. Clair (Illinois) The Record.

Read the rest of this entry »

APP ok to make heparin in Puerto Rico

This week APP Pharmaceuticals, headquartered in Schaumberg, Ill., announced it has gotten approval to manufacture heparin at its Barceloneta, Puerto Rico, facility. The facility will manufacture three product codes of heparin sodium injection, USP.

Read the rest of this entry »